echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Johnson & Johnson will establish a lung cancer treatment center in Shanghai

    Johnson & Johnson will establish a lung cancer treatment center in Shanghai

    • Last Update: 2014-10-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: caixin.com on October 17, 2014, Johnson & Johnson will establish a lung cancer rehabilitation center in Shanghai, and transfer the R & D center in the Asia Pacific region to Shanghai In an exclusive interview with Caixin, Dr bill hait, global R & D director of Johnson & Johnson's Janssen Pharmaceutical, confirmed the above news and said that lung cancer and chronic obstructive pulmonary disease have been on a significant upward trend in China in recent years Caixin's news shows that in order to maintain its leading position in the pharmaceutical industry in China, Johnson & Johnson has formulated an innovation strategy for the Chinese market, which will focus on lung cancer, chronic obstructive pulmonary disease, liver cancer and blood cancer, and give more investment The lung cancer treatment center will also be part of this innovative strategy, but the specific time for its establishment has not been determined Dr Bill Hait, head of global R & D for Johnson & Johnson's Yang Sen pharmaceuticals, said that lung cancer and chronic obstructive pulmonary disease have been on a significant upward trend in China in recent years, mainly due to smoking and air pollution In addition, many lung cancer patients in China also suffer from chronic obstructive pulmonary disease, which will lead to greater demand for such drugs in the future In addition, Shanghai will become Johnson & Johnson's Innovation Center in the Asia Pacific region Together with the rest three innovation centers in Boston, London and California, Shanghai will provide R & D support for Johnson & Johnson's personal care and over-the-counter medicine business, medical equipment and diagnosis business and pharmaceutical business Johnson & Johnson established a global emerging market innovation center in Shanghai in July 2006 and put it into operation in October 2007 It was J & J's first large-scale R & D center in the Asia Pacific region, but it only focused on the R & D of various consumer care products  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.